FLEET ENEMA EXTRA OTC
Generic Name and Formulations:
Monobasic sodium phosphate 19g, dibasic sodium phosphate 7g; per 197mL; latex-free; contains 4.4g sodium per enema.
Fleet, C.B., Company
Indications for FLEET ENEMA EXTRA:
Occasional constipation or bowel cleansing before rectal exam.
1 enema rectally daily; may be used up to 7 days. Results usually within 1–5mins; re-evaluate if no relief after 7 days.
Use other forms.
Megacolon. Bowel obstruction. Imperforate anus. CHF.
Sodium restricted diet. Impaired renal or cardiac function. Electrolyte disturbances. Colostomy. Discontinue if rectal bleeding or if no bowel movement occurs. Frequent use leads to dependence. Pregnancy. Nursing mothers.
Electrolyte imbalances possible with calcium channel blockers, diuretics; use cautiously.
Original enema—133mL; Extra—230mL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy